Validity and reliability of the us national cancer institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
Adverse Drug Reaction Reporting Systems
Drug-Related Side Effects and Adverse Reactions
National Cancer Institute (U.S.)
Surveys and Questionnaires
Terminology as Topic
Evidence demonstrates favorable validity, reliability, and responsiveness of PRO-CTCAE in a large, heterogeneous US sample of patients undergoing cancer treatment. Studies evaluating other measurement properties of PRO-CTCAE are under way to inform further development of PRO-CTCAE and its inclusion in cancer trials.